M.A. Valantin

1.1k total citations
27 papers, 484 citations indexed

About

M.A. Valantin is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, M.A. Valantin has authored 27 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 12 papers in Epidemiology and 10 papers in Virology. Recurrent topics in M.A. Valantin's work include HIV/AIDS drug development and treatment (17 papers), HIV/AIDS Research and Interventions (12 papers) and HIV Research and Treatment (10 papers). M.A. Valantin is often cited by papers focused on HIV/AIDS drug development and treatment (17 papers), HIV/AIDS Research and Interventions (12 papers) and HIV Research and Treatment (10 papers). M.A. Valantin collaborates with scholars based in France, Martinique and Belgium. M.A. Valantin's co-authors include Christine Katlama, Roland Tubiana, André Cabié, Clotilde Allavena, Isabelle Poizot‐Martin, P. Puglièse, Anne Simon, Claudine Duvivier, Stéphanie Dominguez and Jade Ghosn and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Annals of Oncology.

In The Last Decade

M.A. Valantin

24 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Valantin France 13 305 216 159 131 99 27 484
Maria Martínez‐Rebollar Spain 13 507 1.7× 233 1.1× 275 1.7× 173 1.3× 168 1.7× 49 684
Monika Bociąga‐Jasik Poland 12 232 0.8× 156 0.7× 103 0.6× 39 0.3× 38 0.4× 72 454
Thérèse Staub Luxembourg 15 379 1.2× 134 0.6× 251 1.6× 61 0.5× 47 0.5× 29 576
X. de la Tribonnière France 12 256 0.8× 172 0.8× 137 0.9× 35 0.3× 155 1.6× 40 545
Amélie Menard France 11 261 0.9× 85 0.4× 106 0.7× 78 0.6× 128 1.3× 26 497
Iain Reeves United Kingdom 12 173 0.6× 220 1.0× 34 0.2× 67 0.5× 27 0.3× 29 357
Roberta Gagliardini Italy 15 411 1.3× 129 0.6× 281 1.8× 67 0.5× 120 1.2× 65 544
Núria Espinosa Spain 12 141 0.5× 114 0.5× 94 0.6× 89 0.7× 58 0.6× 46 359
N. А. Belyakov Russia 10 150 0.5× 163 0.8× 44 0.3× 25 0.2× 25 0.3× 76 317
Sara Jam Iran 14 120 0.4× 187 0.9× 53 0.3× 81 0.6× 27 0.3× 24 456

Countries citing papers authored by M.A. Valantin

Since Specialization
Citations

This map shows the geographic impact of M.A. Valantin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Valantin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Valantin more than expected).

Fields of papers citing papers by M.A. Valantin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Valantin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Valantin. The network helps show where M.A. Valantin may publish in the future.

Co-authorship network of co-authors of M.A. Valantin

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Valantin. A scholar is included among the top collaborators of M.A. Valantin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Valantin. M.A. Valantin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sagaon‐Teyssier, Luis, M.A. Valantin, Roland Tubiana, et al.. (2025). Uptake of drug-reduced antiretroviral strategies and impact on costs over 2015–22: experience from an HIV clinic in Paris, France. Journal of Antimicrobial Chemotherapy. 80(10). 2825–2833.
2.
Seang, Sophie, Ève Todesco, M.A. Valantin, et al.. (2024). A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia. Infectious Diseases Now. 54(7). 104980–104980. 1 indexed citations
3.
Seang, Sophie, Omar S. Itani, Gentiane Monsel, et al.. (2022). Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up. Infectious Diseases Now. 52(3). 165–169. 20 indexed citations
4.
Palich, Romain, David Bendetowicz, Rachid Agher, et al.. (2021). Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study. Infectious Diseases Now. 51(5). 440–444. 8 indexed citations
5.
Cuzin, Lise, Cyrille Delpierre, Clotilde Allavena, et al.. (2019). Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat’AIDS cohort. PLoS ONE. 14(9). e0222067–e0222067. 13 indexed citations
6.
Hentzien, Maxime, André Cabié, P. Puglièse, et al.. (2018). Factors associated with deaths from suicide in a French nationwide HIV‐infected cohort. HIV Medicine. 19(8). 551–558. 18 indexed citations
7.
Puglièse, P., Véronique Joly, M.A. Valantin, et al.. (2018). Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France. Médecine et Maladies Infectieuses. 49(4). 264–269. 1 indexed citations
8.
Salmon, Dominique, Firouzé Bani‐Sadr, Camille Gilbert, et al.. (2015). HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. Journal of Clinical Virology. 73. 32–35. 1 indexed citations
9.
Spano, Jean‐Philippe, Isabelle Poizot‐Martin, Dominique Costagliola, et al.. (2015). Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group. Annals of Oncology. 27(3). 397–408. 30 indexed citations
10.
Hentzien, Maxime, Moustapha Dramé, Clotilde Allavena, et al.. (2015). Impact of age-related comorbidities on five-year overall mortality among elderly HIV-infected patients in the late HAART era — Role of chronic renal disease. The journal of nutrition health & aging. 20(4). 408–414. 26 indexed citations
11.
Seang, Sophie, Slim Fourati, Catherine Blanc, et al.. (2014). Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study. Journal of Antimicrobial Chemotherapy. 69(12). 3356–3359. 1 indexed citations
12.
13.
Dominguez, Stéphanie, Jade Ghosn, Gilles Peytavin, et al.. (2010). Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study. Journal of Antimicrobial Chemotherapy. 65(11). 2445–2449. 16 indexed citations
14.
Cuzin, Lise, Clotilde Allavena, L. Lévy-Bachelot, et al.. (2010). Tolerance and durability of abacavir/lamivudine (ABC/3TC)‐containing regimens: results from a large prospective French cohort. Journal of the International AIDS Society. 13(S4). 1 indexed citations
15.
Puglièse, P., André Cabié, Isabelle Poizot‐Martin, et al.. (2009). A large French prospective cohort of HIV‐infected patients: the Nadis Cohort. HIV Medicine. 10(8). 504–511. 97 indexed citations
16.
Morand‐Joubert, Laurence, Karine Lacombe, J.‐M. POIRIER, et al.. (2009). Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial. Journal of Antimicrobial Chemotherapy. 65(1). 125–128. 3 indexed citations
17.
Duvivier, Claudine, M.A. Valantin, Nadia Arzouk, et al.. (2009). Kidney Transplantation in HIV-Positive Patients: Report of Our First 7 Cases. Transplantation Proceedings. 41(8). 3301–3304. 5 indexed citations
18.
19.
Amellal, Bahia, Clotilde Allavena, Elisabeth André‐Garnier, et al.. (2007). Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study). Journal of Infection. 54(6). 603–608.
20.
Ghosn, Jade, Vincent Thibault, Claudine Duvivier, et al.. (2004). Acute hepatitis C in HIV‐infected men who have sex with men. HIV Medicine. 5(4). 303–306. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Martínez‐Rebollar Breakdown of academic impact, for papers by Monika Bociąga‐Jasik Breakdown of academic impact, for papers by Thérèse Staub Breakdown of academic impact, for papers by X. de la Tribonnière Breakdown of academic impact, for papers by Amélie Menard Breakdown of academic impact, for papers by Iain Reeves Breakdown of academic impact, for papers by Roberta Gagliardini Breakdown of academic impact, for papers by Núria Espinosa Breakdown of academic impact, for papers by N. А. Belyakov Breakdown of academic impact, for papers by Sara Jam
Rankless by CCL
2026